AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 293: L843-L854, 2007. First published August 10, 2007; doi:10.1152/ajplung.00120.2007
1040-0605/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/4/L843    most recent
00120.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Csortos, C.
Right arrow Articles by Verin, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Csortos, C.
Right arrow Articles by Verin, A. D.

INVITED REVIEW

Regulation of vascular endothelial cell barrier function and cytoskeleton structure by protein phosphatases of the PPP family

Csilla Csortos,1,2 Irina Kolosova,1,3 and Alexander D. Verin1,4

1Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, Illinois; 2Department of Medical Chemistry, Research Center for Molecular Medicine, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary; 3Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Case Western Reserve University, Cleveland, Ohio; and 4Medical College of Georgia, Vascular Biology Center, Augusta, Georgia

Reversible phosphorylation of cytoskeletal and cytoskeleton-associated proteins is a significant element of endothelial barrier function regulation. Therefore, understanding the mechanisms of phosphorylation/dephosphorylation of endothelial cell cytoskeletal proteins is vital to the treatment of severe lung disorders such as high permeability pulmonary edema. In vivo, there is a controlled balance between the activities of protein kinases and phosphatases. Due to various external or internal signals, this balance may be shifted. The actual balances at a given time alter the phosphorylation level of certain proteins with appropriate physiological consequences. The latest information about the structure and regulation of different types of Ser/Thr protein phosphatases participating in the regulation of endothelial cytoskeletal organization and barrier function will be reviewed here.

endothelial barrier function; Ser/Thr protein phosphatases



Address for reprint requests and other correspondence: Alexander D. Verin, Vascular Biology Center, CB-3210A, Medical College of Georgia, Augusta, GA 30912-2500 (e-mail: averin{at}mcg.edu)




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
A. Antonov, C. Snead, B. Gorshkov, G. N. Antonova, A. D. Verin, and J. D. Catravas
Heat Shock Protein 90 Inhibitors Protect and Restore Pulmonary Endothelial Barrier Function
Am. J. Respir. Cell Mol. Biol., November 1, 2008; 39(5): 551 - 559.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. Csortos, I. Czikora, N. V. Bogatcheva, D. M. Adyshev, C. Poirier, G. Olah, and A. D. Verin
TIMAP is a positive regulator of pulmonary endothelial barrier function
Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L440 - L450.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.